2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RDImmunoglobulin G4-Related Disease, autoimmune disease, immune system disorderNot yet recruitingPhase 22026-08-27NCT07222553
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.cardiovascular disorder, vascular disorder, vasculitisActive, not recruitingPhase 32026-07-20NCT06321601